Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000271828, also known as "Novel transcript, antisense to MIER3," is a long non-coding RNA (lncRNA) gene encoded antisense to the coding gene MIER3. It belongs to the lncRNA class and does not code for a protein product. While the function of many antisense lncRNAs involves regulation of neighboring gene expression through processes such as chromatin modification, RNA stability, or transcriptional interference, there are currently no specific mechanistic or disease associations reported for this transcript. It is not classified as a therapeutic target such as a receptor, enzyme, transporter, or similar molecule. ENSG00000271828 is annotated by GeneCards as an RNA gene of the lncRNA class. There is currently no literature or database evidence linking this specific lncRNA to therapeutic targeting, drug interaction, or known disease roles. Antisense lncRNAs are known in general to participate in various regulatory processes, but individual function for this transcript remains uncharacterized as of current profiling. The MIER3 gene, by contrast, is a protein-coding gene involved in chromatin regulation and cancer, but this is not the focus here.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to MIER3.